May 20-24, 2017
Boston, MA
Booth#909
Precision will have a very strong presence again at ISPOR– this year in Boston, MA.
Come see us on the convention floor at Booth #909, and look for our expertise on display in numerous Precision-led short courses, forums, posters, issues panels, workshops and plenary sessions.
Precision for Value Senior Vice President Jorge Font, MPH will be presenting at the 2017 Asembia Specialty Pharmacy Summit with Mercer’s national pharmacy practice leader, David Dross, on the topic of Employer Perspectives on Specialty Pharmacy: Continued Focus on Controlling Rising Costs. The presentation will take place on April 30th at 2:00pm.
At ISPOR’s 19th Annual European Congress, to be held from October 29th – November 2nd, 2016 in Vienna, Austria, Precision will have a very strong presence.
Come visit the Precision team in Booths 1000/900/1001/901!
ISPOR Annual International Meeting
Precision will be exhibiting in booth 81/82
Location: Washington, D.C.
Precision for Value will be at the annual AMCP Managed Care & Specialty Pharmacy Meeting in San Francisco which will be held April 19-22 at the Moscone West convention center in San Francisco, California.
Precision for Value is excited to be leading a presentation at the upcoming AMCP Partnership Forum, FDAMA 114: Improving the Exchange of Pharmacoeconomic Data, to be held March 1-2, 2016 at the Marriott Marquis in Washington, DC.
Precision will be sponsoring, presenting and exhibiting at the World Pharma Pricing & Market Access Congress event in London, England.
Breakout Session, February 9th (two concurrent): Opposing Influences of Evidence and Market Forces in Pharmaceutical Pricing and Payer Net Cost
Larry Blandford – Senior Vice President & Managing Partner, Precision for Value
Steve Carter – Vice President, Pricing and Market Access, Precision for Value
This session will outline the process often used by manufacturers to establish a price for a product and compare that to how payers assess how that cost impacts the perception of value. The presenters will outline how clinical and economic evidence, research, and market forces can shift price points through launch preparation. New research on how payers perceive a product based on price will be unveiled along with implications across different benefits plans, such as Medicare Part D and employer-funded programs. Lastly, evolving and future methods for alignment between these stakeholders will be shared.